Use of Serum Mesothelin as an Indicator of Tumor Progression in Routine Clinical Practice of Malignant Pleural Mesothelioma Treatment

Journal of Thoracic Oncology - United States
doi 10.1016/j.jtho.2018.03.015
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Pleural Fluid Mesothelin as an Adjunct to the Diagnosis of Pleural Malignant Mesothelioma

Disease Markers
BiochemistryMedicineClinical BiochemistryMolecular BiologyGenetics
2014English

Serum Soluble Mesothelin Concentrations in Malignant Pleural Mesothelioma: Relationship to Tumor Volume, Clinical Stage and Changes in Tumor Burden

Clinical Cancer Research
Cancer ResearchOncology
2010English

S21 a Prospective Study Using Serum Mesothelin to Monitor Malignant Pleural Mesothelioma

2017English

Multimodality Treatment of Malignant Pleural Mesothelioma

F1000Research
GeneticsMolecular BiologyPharmacologyBiochemistryMicrobiology ImmunologyMedicineToxicologyPharmaceutics
2018English

Soluble Mesothelin-Related Protein in Pleural Effusion From Patients With Malignant Pleural Mesothelioma

Experimental and Therapeutic Medicine
MedicineCancer ResearchImmunologyMicrobiology
2010English

Malignant Pleural Mesothelioma Presenting as Achalasia.

Internal Medicine
Internal MedicineMedicine
1994English

Malignant Pleural Mesothelioma

Chest
CardiologyCritical CareCardiovascular MedicineIntensive Care MedicinePulmonaryRespiratory Medicine
2009English

Chemotherapy of Malignant Pleural Mesothelioma.

Japanese Journal of Lung Cancer
OncologyRespiratory MedicinePulmonary
1990English

MicroRNAs as Potential Biomarkers in Malignant Pleural Mesothelioma

Current Biomarker Findings
BiochemistryClinical Biochemistry
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy